Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Analysis of Legislative Requirements About Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries.
Kamusheva M, Manova M, Savova AT, Petrova GI, Mitov K, Harsányi A, Kaló Z, Márky K, Kawalec P, Angelovska B, Lakić D, Tesar T, Draganic P, Geitona M, Hatzikou M, Paveliu MS, Männik A. Kamusheva M, et al. Among authors: paveliu ms. Front Pharmacol. 2018 Jul 20;9:795. doi: 10.3389/fphar.2018.00795. eCollection 2018. Front Pharmacol. 2018. PMID: 30079023 Free PMC article.
Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries.
Malinowski KP, Kawalec P, Trąbka W, Czech M, Petrova G, Manova M, Savova A, Draganić P, Vostalová L, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: paveliu ms. Front Pharmacol. 2019 May 8;10:487. doi: 10.3389/fphar.2019.00487. eCollection 2019. Front Pharmacol. 2019. PMID: 31139080 Free PMC article.
Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe.
Malinowski KP, Kawalec P, Trąbka W, Sowada C, Petrova G, Manova M, Savova A, Draganić P, Slabý J, Männik A, Márky K, Rugaja Z, Gulbinovic J, Tesar T, Paveliu MS. Malinowski KP, et al. Among authors: paveliu ms. Orphanet J Rare Dis. 2020 Oct 8;15(1):277. doi: 10.1186/s13023-020-01556-9. Orphanet J Rare Dis. 2020. PMID: 33032634 Free PMC article.
Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania.
Codreanu C, Mogoșan C, Popescu C, Paveliu MS. Codreanu C, et al. Among authors: paveliu ms. Biomed Res Int. 2019 Jun 26;2019:9343812. doi: 10.1155/2019/9343812. eCollection 2019. Biomed Res Int. 2019. PMID: 31346527 Free PMC article.
Estimating an EQ-5D-3L Value Set for Romania Using Time Trade-Off.
Paveliu MS, Olariu E, Caplescu R, Oluboyede Y, Niculescu-Aron IG, Ernu S, Vale L. Paveliu MS, et al. Int J Environ Res Public Health. 2021 Jul 11;18(14):7415. doi: 10.3390/ijerph18147415. Int J Environ Res Public Health. 2021. PMID: 34299864 Free PMC article.
EQ-5D-5L: a value set for Romania.
Olariu E, Mohammed W, Oluboyede Y, Caplescu R, Niculescu-Aron IG, Paveliu MS, Vale L. Olariu E, et al. Among authors: paveliu ms. Eur J Health Econ. 2023 Apr;24(3):399-412. doi: 10.1007/s10198-022-01481-7. Epub 2022 Jun 10. Eur J Health Econ. 2023. PMID: 35688994 Free PMC article.
Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
Olariu E, Caplescu R, Vale L, Niculescu-Aron IG, Oluboyede Y, Paveliu MS. Olariu E, et al. Among authors: paveliu ms. Health Qual Life Outcomes. 2023 Jul 29;21(1):80. doi: 10.1186/s12955-023-02144-8. Health Qual Life Outcomes. 2023. PMID: 37507760 Free PMC article.
11 results